Gobles Man Charged with Selling Mislabeled, Unapproved GLP-1 Drugs

Brandon Piper accused of importing and selling foreign-made medications without prescriptions

Published on Feb. 22, 2026

A 45-year-old man from Gobles, Michigan has been charged with conspiracy to introduce misbranded drugs into interstate commerce. Prosecutors allege that Brandon Piper imported prescription drugs, including GLP-1s, from China and sold them to American consumers online without a prescription through a Canadian company and later a Michigan-based website called Milestone Purity.

Why it matters

The sale of unapproved, mislabeled drugs poses significant health risks to consumers who may unknowingly purchase and use potentially unsafe or ineffective medications. This case highlights ongoing challenges in regulating the online sale of pharmaceuticals and the need for greater oversight to protect public health.

The details

According to prosecutors, Piper worked for a Canadian company that sold non-FDA approved drugs obtained from outside the U.S. to American customers online from October 2023 to August 2024. He then started a new Michigan-based website, Milestone Purity, that continued the same business model, fulfilling orders from a Holland mailing address. Milestone Purity advertised drugs like semaglutide and tirzepatide, which are FDA-approved for type II diabetes and obesity, but sold them to people without prescriptions. The medications were often labeled as 'PRODUCT OF USA' despite being sourced from China.

  • Piper worked for the Canadian company from October 2023 to August 2024.
  • Piper started the Milestone Purity website in August 2024.

The players

Brandon Piper

A 45-year-old man from Gobles, Michigan who has been charged with conspiracy to introduce misbranded drugs into interstate commerce.

Milestone Purity

A Michigan-based website operated by Piper that sold non-FDA approved, mislabeled drugs obtained from China to American consumers without prescriptions.

Got photos? Submit your photos here. ›

What’s next

If convicted, Piper faces up to five years in prison and three years of supervised release.

The takeaway

This case highlights the ongoing challenges in regulating the online sale of pharmaceuticals and the need for greater oversight to protect public health from the risks of unapproved and mislabeled drugs being sold to consumers.